# NanoFUSE® PL Gutter PMCF

> **NCT03751943** · PHASE4 · UNKNOWN · sponsor: **NanoFUSE Biologics, LLC** · enrollment: 50 (estimated)

## Conditions studied

- Degenerative Disc Disease

## Interventions

- **DEVICE:** NanoFUSE® Bioactive Matrix (75%) w/autograft (25%)

## Key facts

- **NCT ID:** NCT03751943
- **Lead sponsor:** NanoFUSE Biologics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01
- **Primary completion:** 2021-03
- **Final completion:** 2021-03
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03751943

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03751943, "NanoFUSE® PL Gutter PMCF". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03751943. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*